Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine
Print Print
Presentation
19 November
Monday 20 November
DAY 1
Room 3ARoom 3BHall 1BHall 1CRoom 11B - WorkshopRoom 11C - WorkshopDAY 2
All times shown are GMT —
DAY 1
Room 3ARoom 3BHall 1BHall 1CRoom 11B - WorkshopRoom 11C - WorkshopDAY 2
08:00 Event Registration 08:00
08:05 08:05
08:10 08:10
08:15 08:15
08:20 08:20
08:25 08:25
08:30 08:30
08:35 08:35
08:40 08:40
08:45 08:45
08:50 08:50
08:55 08:55
09:00 09:00
09:05 09:05
09:10 09:10
09:15 09:15
09:20 09:20
09:25 09:25
09:30 09:30
09:35 09:35
09:40 09:40
09:45 09:45
09:50
Mind the gap… making a career out of building bridges
09:50 (20 mins)
Laura Ajram, Medicines Discovery Catapult  
09:50
09:55 09:55
10:00 10:00
10:05 10:05
10:10 Refreshment Break 10:10
10:15 10:15
10:20 10:20
10:25 10:25
10:30 10:30
10:35 10:35
10:40 10:40
10:45 10:45
10:50
Innovative Strategies Supporting Drug Discovery
Chairs: Kenny Simmen, Johnson & Johnson Innovation  Laura Dickens, UKRI - Medical Research Council   
Disruptive technologies
Chairs: Carolina Wählby, Uppsala University  Mark Roberts, Tessella  
10:50
10:55 10:55
11:00
High-throughput proteomics for gene function prediction, target discovery and precision medicine
11:00 (30 mins)
Markus Ralser, Crick Institute / Dept Biochemistry, Berlin  

The MRC’s COVID-19 Research Response
11:00 (30 mins)
Jonathan Pearce, UKRI- Medical Research Council  

High resolution anatomical mapping of gene expression using targeted in situ sequencing
11:00 (30 mins)
Mats Nilsson, SciLifeLab  

Sir James Black Award Presentation - Anti-CD20, new precision medicines from old targets
11:00 (30 mins)
Daren Austin, GlaxoSmithKline  
11:00
11:05 11:05
11:10 11:10
11:15 11:15
11:20 11:20
11:25 11:25
11:30 11:30
11:35 11:35
11:40 11:40
11:45 11:45
11:50 11:50
11:55 11:55
12:00
Automating Image Analysis with Deep Learning to Accelerate Drug Discovery and Increase Mechanistic Insight
12:00 (30 mins)
James Robinson, AstraZeneca  

Improving diversity in health research and clinical trials
12:00 (30 mins)
Annette Crosse, Egality   

Live cell compatible super resolution fluorescence microscopy for 3D imaging
12:00 (30 mins)
Ilaria Testa, SciLifeLab  Francesca Pennacchietti  

Tracking GPCR signalling- from the outside in one cell at a time
12:00 (30 mins)
Terence Hébert, McGill University  
12:00
12:05 12:05
12:10 12:10
12:15 12:15
12:20 12:20
12:25 12:25
12:30 12:30
12:35 12:35
12:40 12:40
12:45 12:45
12:50 12:50
12:55 12:55
13:00 Refreshment Break
Workshop
Chairs: Lilian Hunt, EDIS, Wellcome Trust  

Equality, Diversity and Inclusion: Awareness to action
13:00 (60 mins)
Lilian Hunt, EDIS, Wellcome Trust  
13:00
13:05 13:05
13:10 13:10
13:15 13:15
13:20 13:20
13:25 13:25
13:30 13:30
13:35 13:35
13:40 13:40
13:45 13:45
13:50 13:50
13:55 13:55
14:00 14:00
14:05 14:05
14:10 14:10
14:15 14:15
14:20 14:20
14:25 14:25
14:30
Generation of fully human antibodies using high throughput IntelliSelect® Technology Platforms at LifeArc
14:30 (30 mins)
Preeti Bakrania, LifeArc  

Alignment of Chemogenomic and Functional Genomic screening for target ID
15:00 (30 mins)
Joanna Redmond, GlaxoSmithKline  

Democratising Drug Discovery – Widening Access to Expertise and Technologies
14:30 (30 mins)
Peter Simpson, Medicines Discovery Catapult  

Open drug discovery on the edge - the COVID Mooonshot's quest for an antiviral pill
15:00 (30 mins)
Frank von Delft, Diamond  

Chemical Materials Design
14:30 (30 mins)
Ben Slater, Materials Innovation Factory (MIF)  

Quantum computing: a new frontier in drug discovery?
15:00 (30 mins)
Sam Genway, Capgemini Engineering  

Effects of small molecule compounds targeting osteoclasts against RA bone destruction
14:30 (30 mins)
Yanhui Tan, Guangxi Normal University, Guilin, China  

Bio-inspired nanoformulations for delivery of advanced therapeutics
15:00 (30 mins)
Rongjun Chen, Imperial College London   

Learn to Learn
14:30 (90 mins)
Chris Williams, Questae Coaching & Consulting Ltd  
14:30
14:35 14:35
14:40 14:40
14:45 14:45
14:50 14:50
14:55 14:55
15:00 15:00
15:05 15:05
15:10 15:10
15:15 15:15
15:20 15:20
15:25 15:25
15:30 Comfort Break 15:30
15:35 15:35
15:40
A Huntington’s disease embryonic stem cell phenotypic HTS to identify small molecule modulators of mutant HTT
15:40 (30 mins)
Marta Stebbeds, Discovery from Charles River  

High-throughput PROTAC synthesis for direct, biological assaying
16:10 (30 mins)
David Battersby, GlaxoSmithKline  

'Virtual Reality’ – Adding a New Dimension to Drug Design
15:40 (30 mins)
Timur Avkiran  

Transforming Research and Medicine through Synthetic Biology
16:10 (30 mins)
Helen Horton, Touchlight  

A structural biology community assessment of AlphaFold 2 applications
15:40 (30 mins)
Pedro Beltrao, EMBL-EBI   

MELLODDY: privacy-preserving federated machine learning across pharma partners
16:10 (30 mins)
Hugo Ceulemans, Janssen Pharmaceutica  
15:40
15:45 15:45
15:50 15:50
15:55 15:55
16:00 16:00
16:05 16:05
16:10 16:10
16:15 16:15
16:20 16:20
16:25 16:25
16:30 16:30
16:35 16:35
16:40 16:40
16:45 16:45
16:50 16:50
16:55 16:55
17:00 17:00
17:05 17:05
17:10 17:10
17:15 17:15
17:20 17:20
17:25 17:25
17:30 17:30
17:35 17:35
17:40 17:40
17:45 17:45
17:50 17:50
17:55 17:55
18:00 18:00
18:05 18:05
18:10 18:10
18:15 18:15
18:20 18:20
18:25 18:25
18:30 18:30
18:35 18:35
18:40 18:40
18:45 18:45
18:50 18:50
18:55 18:55
19:00 19:00